Surlin Petra, Rauten Anne Marie, Mogoantă L, Siloşi Izabella, Oprea B, Pirici D
Department of Periodontology, Faculty of Dentistry, University of Medicine and Pharmacy of Craiova, Romania.
Rom J Morphol Embryol. 2010;51(3):515-9.
Levels of metalloproteinase 8 (MMP8) in gingival crevicular fluid were studied in case of treatment with fixed orthodontic appliances. It were found a relationship between its levels and stages of the treatment under a good control of the bacterial plaque. Gingival overgrowth (GO) during the orthodontic treatment was traditionally considered as an inflammatory reaction consecutive of bacterial plaque accumulation because of difficult hygiene in those patients. Our study starts from the hypothesis that the gingival volume growth during the fixed orthodontic treatment appears at the beginning, without any inflammatory signs, as a result of the mechanical stress and periodontal remodeling during the orthodontic dental movement, the MMP8 acting as an indicator of this situation.
Twenty-two patients received a fixed orthodontic treatment. Periodontal examination took place one hour before and one hour, four and eight hours and weekly after until eight weeks. At each session gingival crevicular fluid (GCF) was sampled and the level of MMP8 was determined. At the appearance of gingival overgrowth (GO) gingivectomy was performed.
In the 13 patients that did not develop gingival overgrowth, the levels of MMP8 increased in the first 4-8 hours after orthodontic appliance and then fall to the initial level. In the nine patients with gingival overgrowth, the MMP8 levels in GCF continued to rise until the appearance of GO. In cases of GO with inflammation the levels of MMP8 were significantly higher than in cases of GO without inflammation. The expression of MMP8 in hypertrophied gingiva was more intensive in cases of GO with inflammation.
It is possible that the MMP8 values in GCF to be a marker of the GO onset. MMP8 determination and monitoring at shorter time intervals may lead to a better control of the bacterial plaque and avoidance of gingival inflammation.
研究了固定正畸矫治器治疗情况下龈沟液中金属蛋白酶8(MMP8)的水平。发现在良好控制菌斑的情况下,其水平与治疗阶段之间存在关联。正畸治疗期间的牙龈增生(GO)传统上被认为是由于这些患者口腔卫生困难导致菌斑积聚而引发的炎症反应。我们的研究基于这样一个假设,即固定正畸治疗期间牙龈体积的增长在开始时没有任何炎症迹象,是正畸牙齿移动过程中机械应力和牙周重塑的结果,MMP8作为这种情况的一个指标。
22名患者接受了固定正畸治疗。在治疗前1小时、治疗后1小时、4小时、8小时以及之后每周直至8周进行牙周检查。在每次检查时采集龈沟液(GCF)并测定MMP8水平。在出现牙龈增生(GO)时进行牙龈切除术。
在13名未发生牙龈增生的患者中,正畸矫治器佩戴后的最初4 - 8小时内MMP8水平升高,然后降至初始水平。在9名发生牙龈增生的患者中,GCF中的MMP8水平持续上升直至出现GO。在伴有炎症的GO病例中,MMP8水平显著高于无炎症的GO病例。在伴有炎症的GO病例中,肥大牙龈中MMP8的表达更为强烈。
GCF中的MMP8值有可能成为GO发生的标志物。更短时间间隔地测定和监测MMP8可能有助于更好地控制菌斑并避免牙龈炎症。